InnoTherapy

InnoTherapy, Inc. is a South Korean medical device company that specializes in the development of hemostatic adhesives designed to address bleeding in various surgical contexts. Founded in 2010 and headquartered in Seoul, the company offers a range of products, including Hemoleast, a surgical hemostatic agent, and InnoSEAL, a topical dressing that transforms into a gel upon contact with blood. Other notable products include Hemo powder, a sprayable hemostatic agent, and EndoSil, which is applied to mucous membranes. InnoTherapy's technology is based on bio-inspired materials that mimic the adhesive properties found in nature, allowing for innovative solutions in medical applications. The company's offerings also include GellySil, a surgical gel hemostatic agent, and specialized tools such as the non-bleeding TOP needle that utilizes the patient's own blood to seal wounds.